A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
Clinical trial NCT04479852 · COMPLETED
Trial details
- NCT number
- NCT04479852
- Sponsor
- Sirtsei Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2022-06-27
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.